The document discusses the history and development of laboratory biosafety and biosecurity practices. It traces the origins of biosafety to 1943 in the US biological weapons program. Over subsequent decades, various government agencies and international organizations published guidelines that established biosafety levels and containment practices based on risk assessments of different pathogens. More recently, regulations have also focused on biosecurity and preventing misuse or theft of dangerous pathogens. International standards for safe transfer and use of organisms modified by biotechnology have also been developed.
Original Description:
Original Title
Notes6 Concepts on Laboratory Biosafety and Biosecurity
The document discusses the history and development of laboratory biosafety and biosecurity practices. It traces the origins of biosafety to 1943 in the US biological weapons program. Over subsequent decades, various government agencies and international organizations published guidelines that established biosafety levels and containment practices based on risk assessments of different pathogens. More recently, regulations have also focused on biosecurity and preventing misuse or theft of dangerous pathogens. International standards for safe transfer and use of organisms modified by biotechnology have also been developed.
The document discusses the history and development of laboratory biosafety and biosecurity practices. It traces the origins of biosafety to 1943 in the US biological weapons program. Over subsequent decades, various government agencies and international organizations published guidelines that established biosafety levels and containment practices based on risk assessments of different pathogens. More recently, regulations have also focused on biosecurity and preventing misuse or theft of dangerous pathogens. International standards for safe transfer and use of organisms modified by biotechnology have also been developed.
Basic concepts on laboratory biosafety and biosecurity
History of laboratory biosafety
❖ Laboratory biosafety and biosecurity traces its history in North America and Western Europe. ❖ Began in 1943, biosafety is rooted in the US biological weapons program, and was ordered by president Franklin Roosevelt. ❖ President Richard Nixon eventually terminated it in 1969 ❖ In 1943, Ira L. Baldwin - became the first scientific director of the Camp Detrick(Fort Detrick). ❖ Newell A. Johnson - designed modifications for biosafety at Camp Detrick. - he developed specific technical solutions such as Class III Safety Cabinets and laminar flow hoods to address specific risks ❖ 1907 and 1908, Arnold Wedum – described the use of mechanical pipettors to prevent laboratory –acquired infections. - moreover, ventilated cabinets, early progenitors to the nearly ubiquitous engineered control now known as the biological safety cabinet, were first documented outside of the US biological weapons programs. ❖ in 1909, a pharmaceutical company in Pennsylvania developed a ventilated cabinet to prevent infection from mycobacterium tuberculosis. ❖ Biosafety practices worldwide were raised during the height of increasing mortality and morbidity due to small pox in 1967. ❖ In 1974, CDC published the Classification of Etiological Agents on the Basis of Hazard, that introduced the concepts of establishing ascending levels of containment associated with risk in handling of groups of infectious microorganism that present similar characteristics. ❖ The National Institute of Health of US published the NIH Guidelines for Research Involving Recombinant DNA Molecules, it explained in detail the microbiological practices, equipment's, and facility necessarily corresponding to four ascending levels of physical containment. ❖ 1983- WHO’s first edition of Laboratory Biosafety manual. ❖ 1984- NIH’s jointly-published first edition of the Biosafety in Microbiological and Biomedical Laboratories. -these documents established the model of biosafety containment levels with certain agents which increased the biosafety levels for biological agents that pose risk to human health ❖ Biosafety Levels – are the technical means of mitigating the risk of accident infection from or release of agents in the laboratory setting as well as the community and environment it is situated in. ❖ Biosafety levels are concentrated in a combination of engineered controls, administrative controls, and practices, the emphasis is clearly on the equipment and facility controls, with little attention given to risk assessment. ❖ This progress in Biosafety practice continued until the emergence of a community of “Biosafety Officers” who adopted the administrative role of ensuring the proper equipment and facility controls are in place based on the specified biosafety level of the laboratory. ❖ Arnold Wedum was recognized as one of the pioneers of biosafety that provided the foundation for evaluating the risk of handling infectious microorganism and for recognizing biological hazards and developing practices, equipment's, and facility safeguards for their control. ❖ 1996 – US government enacted the Selected Agent Regulations to monitor the transfer of a select list of biological agents from one facility to another. ❖ The revision of the Selected Agent Regulations in 2012 sought to address the creation of two tiers of select agents.
⦿ HISTORY OF LABORATORY BIOSECURITY
❖ TIER 1 AGENTS - are materials that pose the greatest risk of deliberate misuse, and the remaining selected agents. This change was intended to make the regulations more risk-based, mandating additional security measures for Tier 1 Agents. ❖ prescribed biosecurity regulations for bioscience facilities. A. Singapore – Biological Agent and Toxic act, similar in scope with the US regulations but with more severe penalties for non compliance. B. South Korea – Act on Prevention of Infectious Disease, was amended to require institutions that work with listed “highly dangerous pathogens” to implement laboratory safety and biosecurity requirements to prevent the loss, theft, diversion, release or misuse of these agents. C. Japan – Infectious Disease Control Law, it established four schedules of select agents that are subject to different reporting and handling requirements or possession, transport, and other activities D. Canada – Canadian containment level (CL) 3 and 4 facilities that work with risk group 3 and 4 are required to undergo certification. E. Danish – passed a law that gives the Minister of Health and Prevention the authority to regulate the possession, manufacture, use storage, sale, purchase or other transfer , distribution, transport, and disposal of listed biological agents.
⦿ GUIDELINES ON LABORATORY BIOSAFETY AND BIOSECURITY
❖ WHO in 1983, published its 3rd edition of Laboratory Safety Manual. Its include the different levels of containment laboratories (Biosafety 1-4), different biological safety cabinets, good microbiological techniques, and how to disinfect and sterilize equipment. ❖ in terms of Biosecurity, it covers the packing required by inter national transport regulations and other types of safety procedure chemical, electrical, ionizing radiation, and fire hazard. ❖ The Cartagena Protocol on biosafety (CPB), made effective in 2003 which applies to the 168 member-countries provides an international regulatory framework to ensure “ an adequate level of protection in the in the field of safe transfer, handling, and use of living modified organisms (LMOs) resulting from modern biotechnology”. ❖ The new National Committee on Biosafety of the Philippines (NCBP), established under E.O. 430 series of 1990 was formed on the advocacy efforts of the scientist. ❖ NCBP focuses on the organizational structure for biosafety: o procedures for evaluation of proposal with biosafety concerns o Procedures and guidelines in the introduction, movement, and filed release of regulated materials,.. o Procedure on physico-chemical and biological containment. ❖ March 17, 2006, Office of the President promulgated E.O. 514 establishing the National Biosafety Frame work.